NCT03913728View on ClinicalTrials.gov

Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Drug level blood tests

All information included previously.

OTHER

Telephone Interview

All information included previously.

Trial Locations (1)

OL1 1NL

Pennine MSK, Oldham

All Listed Sponsors
lead

University of Manchester

OTHER

NCT03913728 - Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback | Biotech Hunter | Biotech Hunter